Corporate debt recently passed the $1 trillion mark in a continuing sign of global financial displacement.Marketsread more
"Federal debt, which is already high by historical standards, is on an unsustainable course," CBO director Phillip Swagel said in the report.Politicsread more
Target CEO Brian Cornell still thinks the U.S. consumer is strong and spending. Target's latest quarterly results showed the big-box retailer is benefiting from that.Retailread more
Stocks rose on Wednesday as strong quarterly results from retailers such as Target and Lowe's lifted investor sentiment.US Marketsread more
President Trump insists the economy is healthy and says the only thing holding U.S. growth back is the Federal Reserve.Marketsread more
Trading volumes this week are well below their recent averages and that means this comeback may be suspect.Marketsread more
The rule could defy a 2015 Flores Settlement Agreement court order that says families cannot be held in detention for more than 20 days.Politicsread more
Bank of America CEO Brian Moynihan is not worried about an economic slowdown, saying the U.S. consumer is still in a strong place.Banksread more
In a second-round of tweets aimed at the U.S. central bank, the president asked, "WHERE IS THE FEDERAL RESERVE?"Marketsread more
J.P. Morgan Chase customers will no longer be able to pay with their phones in stores beginning next year.Marketsread more
(For a live blog on European stocks, type LIVE/ in an Eikon news window)
* FTSE 100 up 0.2%, FTSE 250 up 0.1%
* Pharma giant AstraZeneca biggest boost
* Insurer Admiral jumps after profit beat
Aug 14 (Reuters) - UK shares gained for a second straight session on Wednesday over hopes of an improvement in global trade relations after Washington delayed imposing tariffs on some Chinese goods, while insurer Admiral rose after reporting a market-beating profit.
The FTSE 100 index added 0.2% and the FTSE 250 midcap index rose 0.1% by 0707 GMT.
Admiral jumped 6% to the top of the main bourse after the company posted a bigger-than-expected rise in earnings, driven by more customers in its UK business.
Drugmaker AstraZeneca rose nearly 2%, providing the biggest support to the index, after its drug Lynparza met the primary endpoint in a phase III trial for ovarian cancer treatment.
Infrastructure company Balfour Beatty and Cybersecurity firm Avast were at the top of the midcap index with gains of 6.7% and 4.2%, respectively, after strong results. (Reporting by Muvija M and Shashwat Awasthi in Bengaluru; Editing by Shounak Dasgupta)